Imetelstat Synthesis Removing Capping Step
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The existing synthesis process for imetelstat, a potent telomerase inhibitor, requires a capping step to prevent unreacted 3′-amino groups from reacting during subsequent cycles, which is unnecessary and increases process time and solvent consumption.
Innovation Solution
A 3-step per cycle solid-phase support bound process is used to synthesize imetelstat without an additional capping step, reducing the number of cycle steps by 22% and consequently reducing process time and solvent consumption.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If a capping step is added to prevent unreacted 3'-amino groups from reacting during subsequent cycles, then the reliability of the synthesis process is improved, but the productivity and process efficiency deteriorate due to increased process time and solvent consumption
Solution Approach 1:
The invention extracts and eliminates the unnecessary capping step from the traditional 4-step synthesis cycle. By removing this redundant step, the process achieves both goals: maintaining synthesis reliability through the inherent stability of the 3'-amino group under the specific reaction conditions, while simultaneously improving productivity by reducing process time and solvent consumption by approximately 22%.
2Manufacturing precision
If a capping step is added to prevent unreacted 3'-amino groups from reacting, then the manufacturing precision is improved, but the loss of time and solvent increases
Solution Approach 1:
The invention applies the self-service principle by designing a synthesis system where the 3'-amino group inherently protects itself from unwanted reactions under the specific reaction conditions used. The amino group's chemical stability under these conditions eliminates the need for external capping intervention, thereby maintaining manufacturing precision while avoiding time loss.
3Manufacturing precision
If a capping step is added to prevent unreacted groups from reacting, then the purity of the final product is improved, but the solvent consumption increases
Solution Approach 1:
The invention extracts and removes the capping step that consumes additional solvents. By eliminating this step, the process reduces solvent consumption significantly while maintaining product purity through the inherent chemical stability of the unreacted 3'-amino groups under the optimized reaction conditions.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process achieves nearly identical yield and purity to the traditional 4-step cycle method, while offering a more efficient and environmentally friendly synthesis of imetelstat.
Implementation Method 1
deprotection of the 3'-amino group of the support-bound oligonucleotide
Implementation Method 2
coupling with a 5'-phosphoramidite
Implementation Method 3
sulfurization with an acyl disulfide
Data Source
AI summary
The present invention relates to a process for preparing the telomerase inhibitor imetelstat using a 3 steps per cycle solid-phase support bound process comprising the steps of deprotection of the 3′-amino group of the support-bound oligonucleotide, coupling with a 5′-phosphoramidite, and sulfurization with an acyl disulfide, characterized by the absence of an additional capping step in each cycle that is used to prevent unreacted 3′-amino oligonucleotide groups from reacting during subsequent cycles. Imetelstat has formula below.